Pfizer Acquires Medivation
Davis Polk is advising J.P. Morgan Securities as financial adviser to Medivation, Inc. in connection with its approximately $14 billion acquisition by Pfizer Inc. The acquisition, which is…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Davis Polk Advises Aetna on the Sale of Medicare Advantage Assets to Molina Healthcare
Davis Polk is advising Aetna Inc. in connection with the sale by Aetna and Humana Inc. of certain of their respective Medicare Advantage assets to Molina Healthcare, Inc. for a total…
Laboratory Corporation of America Holdings Acquires Sequenom, Inc.
Davis Polk is advising JP Morgan as financial adviser to Sequenom, Inc. in connection with its $371 million acquisition by Laboratory Corporation of America Holdings. The closing of the…
McKesson formation of a new company with Change Healthcare Holdings
Davis Polk advised McKesson Corporation on its creation of a new health care information technology company, which will combine substantially all of Change Healthcare Holdings, Inc.’s…
Medtronic Acquires HeartWare International
Davis Polk is advising Perella Weinberg as financial adviser to HeartWare International, Inc. in connection with its $1.1 billion acquisition by Medtronic plc. Under the terms of the…
Anacor $5.2 billion acquisition by Pfizer
Davis Polk is advising Anacor Pharmaceuticals, Inc. on its approximately $5.2 billion acquisition by Pfizer Inc. The closing of the transaction, which is expected in the third quarter…
Davis Polk Advises Verisk Analytics on the Sale of Its Health Care Services Business to Veritas Capital
Davis Polk is advising Verisk Analytics, Inc. in connection with the $820 million sale of Verisk’s health care services business, Verisk Health, to Veritas Capital. The transaction,…
Abbott Acquires Alere
Davis Polk is advising JP Morgan as financial adviser to Alere Inc. in connection with its $5.8 billion acquisition by Abbott Laboratories. The transaction is subject to the approval of…
Stryker Acquires Sage Products from Madison Dearborn Partners
Davis Polk is advising JP Morgan as financial adviser to Stryker Corporation in connection with its $2.775 billion acquisition of Sage Products, LLC from Madison Dearborn Partners. The…
Biotie acquisition by Acorda
Davis Polk is advising Biotie Therapies Corp. in connection with its combination agreement with Acorda Therapeutics, Inc. where Acorda will make a public tender offer in Finland and the…